Summary: Serine protease inactivators (serpins) are important regulators in biochemistry. Often it is necessary to block the serpin action, that is, to stabilize the sample. The guanidine group of arginine is the ligand for the active center pocket of many serine proteases. Arginine or guanidine inhibits serine proteases, and arginine belongs to the reactive P1-P1´ center of many serpins. The plasmatic antithrombin, antiplasmin, or anti-C1-esterase activity was determined: A total of 20 µL of pooled normal plasma or 7% human albumin was added to 100 µL of 0-2.67 M arginine, pH 8.6, 10 µL of 26 mIU/mL thrombin in 7% human albumin, and 30 µL of 1.7 mM CHG-Ala-Arg-pNA (37°C). ∆A at 405 nm was determined, by using a microtiter plate reader. Thrombin was substituted by plasmin or C1-esterase, and the chromogenic peptide substrates <Glu-Phe-Lys-pNA or MeOC-Lys(eCBO)-Gly-Arg-pNA, respectively, were used. The IC 50 of arginine against plasmatic antithrombin activity is 580 mM; the IC 25 is 440 mM. The IC 25 of arginine against plasmatic α 2 -antiplasmin or C1-inactivator is 1650 mM. The amidolytic activity of thrombin, plasmin, and C1-esterase is inhibited similarly by arginine: the IC 50 for arginine against the amidolytic activity of these proteases is about 400 mM. Arginine at very high concentrations inhibits serpins. This is important, if stabilization of a biological fluid is a prerequisite for valid activities of serine proteases. In addition, these high concentrations of arginine might be a new gentle principle to inhibit pathogens that need serpins for their pathophysiology. 
Inhibition of α α 2 -Antiplasmin by Arginine
A total of 20 µL of pooled normal plasma or 7% human albumin was added to 100 µL of 0-2.67 M arginine, pH 8.6. A total of 10 µL of 1.25 µg/mL plasmin (Chromogenix-Haemochrom, Essen, Germany; freshly prepared from an aliquoted frozen stock solution of 125 µg/mL plasmin in 20% glycerol) in 7% albumin (or in 3.6% albumin and 30 µL of plasma or H 2 O for RT incubation) and 30 µL of 1.5 mM <Glu-Phe-Lys-pNA (S-2403; Chromogenix; 1.7 mM for RT) in H 2 O were added, and the ∆A at 405 nm (37°C or RT) was determined.
Inhibition of C 1 -Inactivator by Arginine
A total of 20 µL of pooled normal plasma or 7% human albumin was added to 100 µL of 0-2.67 M arginine, pH 8.6, and 10 µL of C1-esterase reagent (Berichrom C1-Inhibitor; Dade-Behring). After 4 minutes (RT) 30 µL of 1.7 mM MeOC-Lys(eCBO)-Gly-Arg-pNA in 3.3% polypropylene glycol was added and ∆A at 405 nm (37°C) was determined.
Inhibition of Serpins by Arginine
The activities of the serpins antithrombin, α 2antiplasmin, and C 1 -inactivator were calculated and compared (%) to the control serpin activity = 100 -[(protease activity in plasma/protease activity in albumin) * 100]. The 100% control was the serpin activity in 96 mM final arginine concentration.
RESULTS AND DISCUSSION
Thrombin inhibition of plasma disappears at final arginine concentrations greater than 1 mol/L ( Fig. 1A-B ). The inhibition of antithrombin by arginine is independent of heparin. Without the addition of arginine an unspecific HD-CHG-Ala-Arg-pNA cleaving activity appears. This might be due to the 8-fold dilution of 20 µL of plasma (Fig. 1A) or the 6-fold dilution of 30 µL of plasma (Fig. 1B) . This unspecificity disappears at final arginine concentrations of at least 96 mM. Possibly contact factors of hemostasis, such as pre-kallikrein, are folded by dilution of plasma into an active enzyme; that is, if in a chromogenic thrombin assay plasma dilution is necessary, plasma should be diluted with arginine, resulting in a final arginine concentration of more than 100 mM.
Even final arginine concentrations of 1000-1700 mM do not result in a loss of plasmin inhibition of plasma ( Fig. 2A-B ). Arginine concentrations of about 100-200 mM induce an increase of antiplasmin activity of plasma, possibly due to separation of plasmin from reversibly inhibitory components of plasma (α 2 -macroglobulin or fibrinogen derivatives) and subsequent inhibition of plasmin by α 2 -antiplasmin. The chromogenic substrate used to detect plasmin, <Glu-Phe-Lys-pNA, does not show the marked dilution unspecificity of the thrombin substrate. However, dilution unspecificity occurs also with the C1-esterase substrate MeOC-Lys(eCBO)-Gly-Arg-pNA ( Fig. 3) . Similarly as α 2 -antiplasmin, C 1 -INA is relatively resistant to arginine, too. Figure 4 demonstrates the inhibition of serine proteases by arginine: the amidolytic activity of thrombin, plasmin, and C1-esterase is inhibited similarly by arginine. The IC 50 for arginine against the amidolytic activity of these proteases is about 400 mM. Figure 5 shows a comparison of the serpin inhibiting power of arginine: The IC 50 of arginine against plasmatic antithrombin activity is 580 mM; the IC 25 is 440 mM. The IC 25 of arginine against plasmatic antiplasmin or C 1 -inactivator is 1650 mM. The 0 mM arginine values were omitted because of the above-described dilution unspecificities; the 100% control serpin activity was defined as the serpin activity in the 96 mM final concentration of arginine.
The present work shows that arginine at very high concentrations inhibits serpins. This is important if stabilization of a biological fluid is a prerequisite for valid activities of serine proteases. In addition, these high concentrations of arginine might be a new gentle principle to inhibit pathogens that need serpins for their pathophysiology (15) . 
